Discontinued — last reported Q3 '25

Change in Inventories

Operating

Eli Lilly Change in Inventories remained flat by 0.0% to $1.17B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 86.3%, from $626.85M to $1.17B. Over 4 years (FY 2021 to FY 2025), Change in Inventories shows an upward trend with a 110.9% CAGR. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementCash Flow Statement
SectionOperating
CategoryEfficiency
SignalLower is better
VolatilityModerate
First reportedQ1 2007
Last reportedQ3 2025

How to read this metric

An increase in inventory consumes cash and may signal overstocking or anticipated demand, while a decrease releases cash.

Detailed definition

The net change in the value of raw materials, work-in-progress, and finished goods held by the company. For a software-c...

Peer comparison

Relevant for tech companies with hardware divisions, such as those producing gaming consoles or personal computers.

Metric ID: cf_change_in_inventories

Historical Data

5 years
 FY'21FY'22FY'23FY'24FY'25
Value$235.90M$599.70M$1.43B$2.51B$4.67B
YoY Change+154.2%+137.6%+76.0%+86.3%
Range$235.90M$4.67B
CAGR+110.9%
Avg YoY Growth+113.5%
Median YoY Growth+112.0%
Current Streak4+ years growth

Change in Inventories at Other Companies

Frequently Asked Questions

What is Eli Lilly's change in inventories?
Eli Lilly (LLY) reported change in inventories of $1.17B in Q4 2025.
How has Eli Lilly's change in inventories changed year-over-year?
Eli Lilly's change in inventories increased by 86.3% year-over-year, from $626.85M to $1.17B.
What is the long-term trend for Eli Lilly's change in inventories?
Over 4 years (2021 to 2025), Eli Lilly's change in inventories has grown at a 110.9% compound annual growth rate (CAGR), from $235.90M to $4.67B.
What does change in inventories mean?
The change in the amount of physical products held in stock.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.